Oshima_2014_Psychiatry.Res_224_319

Reference

Title : Left frontal lobe hypoperfusion and depressive symptoms in Alzheimers disease patients taking cholinesterase inhibitors - Oshima_2014_Psychiatry.Res_224_319
Author(s) : Oshima E , Terada S , Sato S , Ikeda C , Oda K , Inoue S , Kawada K , Yokota O , Uchitomi Y
Ref : Psychiatry Res , 224 :319 , 2014
Abstract :

Depressive symptoms are common in patients with Alzheimers disease (AD) and increase the caregiver burden. Many studies have reported dorsolateral prefrontal hypometabolism or hypoperfusion in AD patients with depressive symptoms, most of whom did not take acetylcholinesterase inhibitors (AChEI). It is not clear, however, whether a similar condition is present in patients taking AChEI medication. Fifty-seven consecutive AD patients taking AChEI were recruited at a memory clinic. Objective depressive symptoms were evaluated using the depression domain of the Neuropsychiatric Inventory (NPI-dep). All patients underwent brain single photon emission computed tomography (SPECT) with 99mTc-ethylcysteinate dimer, and the SPECT images were analyzed using the Statistical Parametric Mapping 8 program. No significant differences between groups with positive and negative NPI-dep scores were found with respect to age, sex, years of education, and cognitive function. Compared with patients with negative NPI-dep scores, patients with NPI-dep scores >/=1 showed significant hypoperfusion in the left middle frontal region. Our results indicate that the dorsolateral prefrontal area is significantly involved in the pathogenesis of depressive symptoms in AD patients being treated with AChEI. The area on the left side especially may be closely related to the depressive symptoms evaluated using the NPI.

PubMedSearch : Oshima_2014_Psychiatry.Res_224_319
PubMedID: 25453992

Related information

Citations formats

Oshima E, Terada S, Sato S, Ikeda C, Oda K, Inoue S, Kawada K, Yokota O, Uchitomi Y (2014)
Left frontal lobe hypoperfusion and depressive symptoms in Alzheimers disease patients taking cholinesterase inhibitors
Psychiatry Res 224 :319

Oshima E, Terada S, Sato S, Ikeda C, Oda K, Inoue S, Kawada K, Yokota O, Uchitomi Y (2014)
Psychiatry Res 224 :319